What is William Blair's rating on DNA?

William Blair rates DNA Underperform, a bearish rating, as of May 10, 2024.

When did William Blair last change its view on DNA?

On May 10, 2024, William Blair downgrades to Underperform from Mkt Perform.

William Blair DNA price target and rating history

Ginkgo Bioworks Holdings Inc. (DNA) · Health Care

William Blair rates Ginkgo Bioworks Holdings Inc. (DNA) Underperform, as of its latest action on May 10, 2024. It has published 3 rating actions on DNA since October 2021, including 0 upgrades and 2 downgrades.

Current rating: Underperform
Price target: Not stated
Median target, all firms: Too few
Actions on DNA: 3

Every William Blair rating on DNA

May 10, 2024
DowngradeWilliam Blair downgrades to Underperform from Mkt Perform
May 11, 2023
DowngradeWilliam Blair downgrades to Mkt Perform from Outperform
Oct 12, 2021
InitiateWilliam Blair starts coverage at Outperform

Questions about William Blair and DNA

What is William Blair's rating on DNA?: William Blair rates DNA Underperform, a bearish rating, as of May 10, 2024.
When did William Blair last change its view on DNA?: On May 10, 2024, William Blair downgrades to Underperform from Mkt Perform.

More DNA rating histories

All William Blair ratings DNA news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.